Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    17582225 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed OmegAD (Omega-3 and Alzheimer's Disease)
Condition: Alzheimer's Disease
Intervention: Drug: EPAX 1050TG

Indicates status has not been verified in more than two years